Credit Suisse’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Credit Suisse’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,488	Closed	-$24K	–	4802
2014 Q2	$24K	Buy	10,488 +106	+1%	+$263	﹤0.01%	4628
2014 Q1	$31K	Sell	10,382 -2,462	-19%	-$8.11K	﹤0.01%	4606
2013 Q4	$40K	Buy	+12,844	New	+$35.8K	﹤0.01%	4540

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NPC

National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Credit Suisse's ECTE Position: Q3 2014 in Review

Credit Suisse sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2014, closing a stake of 10,488 shares — an estimated $24K sold.

Credit Suisse first reported a position in ECTE in Q4 2013 and held it in 3 quarters. The position peaked at $40K in Q4 2013. 26 funds tracked by Wall St. Rank hold ECTE as of Q3 2014.

Credit Suisse reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2014 after selling out during the quarter.
Credit Suisse sold 10,488 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2014, an estimated $24K.
Credit Suisse first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and held it in 3 quarters.
Credit Suisse's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $40K in Q4 2013.
26 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2014.

Based on Credit Suisse's 13F filing for Q3 2014, filed 14 Nov 2014.